MaxCyte
MXCT
MXCT
130 hedge funds and large institutions have $45.9M invested in MaxCyte in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
53% less capital invested
Capital invested by funds: $98M → $45.9M (-$52.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
130
Holding in Top 10
1
Calls
–
Puts
$1K
Top Buyers
| 1 | +$7.66M | |
| 2 | +$2.04M | |
| 3 | +$1.24M | |
| 4 |
Renaissance Technologies
New York
|
+$1.13M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.05M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$1.83M | |
| 3 | -$1.17M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.08M |
| 5 |
Morgan Stanley
New York
|
-$696K |
